Quadrant Capital Group LLC Elanco Animal Health Inc Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 5,133 shares of ELAN stock, worth $56,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,133
Previous 5,148
0.29%
Holding current value
$56,052
Previous $75,000
17.33%
% of portfolio
0.0%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$908 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$559 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$254 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$223 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.18B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...